Breast Implant Market Snapshot
|Fastest Growing Market:||Europe|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The Breast Implant Market is expected to register a CAGR of 5.3% over the forecast period (2022-2027).
The COVID-19 had a short-term impact on the breast implant market, primarily in the initial phase of the pandemic when the whole world went into lockdown and other travel restrictions to curb the spread of infection due to the SARS-CoV-2 virus. Due to restrictions and lockdown, the ongoing and scheduled surgical procedures were delayed or canceled, which negatively impacted the breast implant market. However, the interest and demand for beauty procedures increased during the COVID-19 period among women in the United States, including breast implant and augmentation. For instance, according to the April 2021 survey report by the American Society of Plastic Surgeons, 11% of the surveyed women were more inclined towards cosmetic surgery or non-surgical procedures than before COVID-19. Therefore, the market is expected to recover soon from the impact of the COVID-19 pandemic and grow in the future.
The rising prevalence of breast cancer worldwide is one of the significant factors for the growth of the breast implant market. According to GLOBOCAN 2020, breast cancer surpassed lung cancer and became the most diagnosed cancer worldwide. According to World Health Organization, in 2020, around 2.3 million women were diagnosed with breast cancer, and 685,000 of them died globally. Also, about 7.8 million women were alive diagnosed with breast cancer in the last five years. While, in Asian women, the breast cancer prevalence was so high that it accounted for 22.9% of the total cancer cases in women in 2020. Another factor that will boost the growth of the studied market is increasing the inclination and awareness of women worldwide towards breast augmentation and reconstruction procedures for beauty enhancement. For example, as per the 2019 International Society for Aesthetic Plastic Surgeons (ISAPS) statistics, there were about 1,795,551 breast augmentation procedures worldwide in 2019, which was more than any other performed aesthetic surgery.
Additionally, the market players in the area are continuously working towards better and efficient solutions and evolving the life of available products through new product launches, collaborations, and mergers and acquisitions, which will also complement the growth of the breast implant market. For instance, in November 2019, Evonik and BellaSeno GmBH announced a partnership agreement to develop innovative breast implant technology using RESOMER bioresorbable polymer. However, the post-surgery complications and risks associated with the breast implant, along with the high cost associated with the implant, are the major restraining factors for the growth of the breast implant market as there is a high misconception about the post-surgical complications and risks from the breast implant in the women.
Scope of the Report
As per the scope of this report, breast implants are medical devices used to augment the size of breasts, either for cosmetic applications or reconstruction purposes, or to correct a congenital abnormality. The procedure involves the usage of breast implants, in order to enhance and improve the size of the breasts. The breast implant market is segmented by type (silicone implants, form-stable implant, saline implant, and structured saline implant), application (reconstructive surgery, and cosmetic surgery), end-user (hospital, cosmetology clinics, and others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
|Structured Saline Implant|
|By End User|
Key Market Trends
Silicone Implant is Expected to be Occupy Major Share in the Market Over Other Types in the Forecast Period
Silicone implants are silicone shells filled with a plastic gel (silicone) that resembles human fat because of its viscosity and are used for breast augmentation or breast reconstruction. Compared to other types of implants, they feel more natural breast tissue which is the primary reason why it is the preference of the majority of people seeking breast implants compared to other kinds. The silicone breast implants are approved for breast augmentation in women of age 22 or older and for breast reconstruction in women of any age by the United States Food and Drug Administration.
Also, the new technological advancements and improvements in the existing products of the silicone breast implant for breast augmentation and reconstruction will boost the growth of the breast implant market. For instance, in May 2021, GC Aesthetics, Inc., a silicone breast implant manufacturer, announced the launch of a next-generation breast implant called PERLE, a smooth breast implant with the proprietary surface technology called BioQ. Thus, due to the high demand for silicone-based breast implants, the market is expected to grow during the forecast period.
To understand key trends, Download Sample Report
North America is Expected to Dominate the Market Over the Forecast Period
North America holds a significant share of the breast implant market. It is expected to show a similar trend over the forecast period, mainly due to the high demand for breast augmentation surgeries due to several entertainment industries in the region and self-awareness among women. In North America, the United States is expected to hold the largest market for breast implants in the region during the forecast period.
The demand for cosmetic surgeries and procedures in the United States is very high among women, which is one of the significant factors for the growth of the breast implant market in the region. For instance, according to the 2020 report of the American Society of Plastic Surgeons, breast augmentation was one of the top five cosmetic surgical procedures performed in 2020 in the United States. Moreover, the total number was 193,073 breast augmentation procedures in 2020. In addition, the increasing prevalence of breast cancer in North America will also complement the growth of the breast implant market in the region. As per the GLOBOCAN 2020 report, the new breast cancer cases in the United States, Canada, and Mexico were 253,465: 28,026; and 29,929, respectively, in 2020. Therefore, North America is expected to hold a significant market share in the breast implant market during the forecast period.
To understand geography trends, Download Sample Report
The breast implant market is moderately competitive owing to the presence of small and large market players who offers a range of implants for breast augmentation, reconstruction, or other cosmetic procedures and are actively involved in enhancing their offering in the market. Some of the market players are AbbVie Inc. (Allergan plc), Establishment Labs SA, GC Aesthetics, Groupe Sebbin SAS, Laboratories Arion, Johnson & Johnson (Mentor Worldwide LLC), Polytech Health & Aesthetics GmbH, and others.
- In August 2020, Hair Diagnostix announced the launch of an advanced and easy-to-use self-test to detect leaking breast implants.
- In June 2020, Allergan Aesthetics, a part of AbbVie Inc. announced the initiation of a digital campaign to improve the device tracking, identification, and increase its reach to patients having Allergan breast implant called BIOCELL and to inform them about the risks of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence of Breast Cancer
4.2.2 Increasing Number of Breast Augmentation Procedures
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Post Complications and Risks Associated with Breast Implants
4.3.2 High Cost of Breast Implants
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.1 Silicone Implant
5.1.2 Form-stable Implant
5.1.3 Saline Implant
5.1.4 Structured Saline Implant
5.2 By Application
5.2.1 Reconstructive Surgery
5.2.2 Cosmetic Surgery
5.3 By End User
5.3.2 Cosmetology Clinic
5.4.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
5.4.3 Asia - Pacific
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.4.4 Middle East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle East and Africa
5.4.5 South America
18.104.22.168 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 AbbVie Inc. (Allergan plc)
6.1.2 Establishment Labs S.A.
6.1.3 GC Aesthetics
6.1.4 Groupe Sebbin SAS
6.1.5 Laboratories Arion
6.1.6 Johnson & Johnson (Mentor Worldwide LLC )
6.1.7 Polytech Health & Aesthetics GmbH
6.1.9 Sientra Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Global Breast Implant Market market is studied from 2019 - 2027.
What is the growth rate of Global Breast Implant Market?
The Global Breast Implant Market is growing at a CAGR of 5.3% over the next 5 years.
Which region has highest growth rate in Global Breast Implant Market?
Europe is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global Breast Implant Market?
North America holds highest share in 2021.
Who are the key players in Global Breast Implant Market?
Establishment Labs SA, GC Aesthetics, Laboratories Arion, Groupe Sebbin SAS, AbbVie Inc. are the major companies operating in Global Breast Implant Market.